PharmaSGP Holding SE (XTER:PSG) Short-Term Debt : €0.0 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE Short-Term Debt?

PharmaSGP Holding SE's Short-Term Debt for the quarter that ended in Sep. 2024 was €0.0 Mil.

PharmaSGP Holding SE's annual Short-Term Debt declined from Dec. 2021 (€85.0 Mil) to Dec. 2022 (€0.0 Mil) but then stayed the same from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil).

PharmaSGP Holding SE Short-Term Debt Historical Data

The historical data trend for PharmaSGP Holding SE's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE Short-Term Debt Chart

PharmaSGP Holding SE Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

85.00

PharmaSGP Holding SE Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

PharmaSGP Holding SE Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PharmaSGP Holding SE Short-Term Debt Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaSGP Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » Short-Term Debt

Traded in Other Exchanges

PSG:Germany

Address

Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166

Website

https://www.sgp-pharma.com

PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.

Executives

Dr. Clemens Fischer	Supervisory Board
Madlena Hohlefelder	Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines